Photo of Aaron Bean
R United States House · District 4 · Florida On the 2026 ballot

Rep. Aaron Bean

Compare
Total votes
1,860
all sessions
Attendance
100%
6 missed
Higher than 97% of chamber peers
With party
92%
of cast votes
Lower than 89% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 88% of chamber peers
Sponsored
458
bills & resolutions
Near the chamber average
Committees
4
assignments
458 bills and resolutions

Sponsored bills

Total
458
Primary
45
Co-sponsor
413
This page
458
matching current filters
Co-sponsor HR 1949
Passed · Texas House · Co-sponsor
Unlocking our Domestic LNG Potential Act of 2025

Maddy summaryThis bill amends the Natural Gas Act to give the Federal Energy Regulatory Commission (FERC) exclusive authority to approve U.S. LNG export terminal projects, requiring FERC to deem such exports consistent with the public interest. It directly affects natural gas companies seeking to build or expand export facilities and streamlines FERC's review process by removing prior requirements for interagency coordination. The bill clarifies that FERC's decisions won't override existing sanctions laws, including restrictions on trade with countries designated as state sponsors of terrorism under current law. This change aims to accelerate domestic LNG export projects while maintaining legal safeguards for national security and foreign policy.

Passed Dec 8, 2025 1 co-sponsor
Co-sponsor HR 6466
In committee · Texas House · Co-sponsor
Forced Abortion Prevention and Accountability Act

Maddy summaryHR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.

In committee Dec 4, 2025 1 co-sponsor
Co-sponsor HR 6469
In committee · Texas House · Co-sponsor
FREEDOM Act

Maddy summaryThis bill (HR 6469) requires the U.S. State Department, in coordination with the FCC and Treasury, to submit a report within 120 days of enactment assessing internet access options in Iran. The report must evaluate the feasibility of using direct-to-cell wireless technology to expand internet access there, including technical, security, and regulatory considerations. It also analyzes how drone-based systems and signal jamming could affect such technology, surveys Iranian telecom providers (including state ownership and foreign investment), and examines broader implications for communications freedom. The bill does not enact new policy but mandates a government review of potential technological solutions.

In committee Dec 4, 2025 1 co-sponsor
Co-sponsor HR 2965
Passed · Texas House · Co-sponsor
Small Business Regulatory Reduction Act of 2025

Maddy summaryHR 2965, the Small Business Regulatory Reduction Act of 2025, requires the Small Business Administration (SBA) to ensure that the cost to small businesses from federal agency rulemaking (including new rules, modifications, or repeals) does not exceed zero starting in fiscal year 2026. It mandates the SBA’s Office of Advocacy to annually report to Congress on all federal rules affecting small businesses, broken down by the issuing agency. The bill applies to all federal agencies, not just the SBA, and focuses on controlling regulatory costs for small businesses. No new funding is provided to implement these requirements.

Passed Dec 4, 2025 1 co-sponsor
Primary HR 1049
Passed · Texas House · Lead sponsor
Transparency in Reporting of Adversarial Contributions to Education Act

Maddy summaryHR 1049 requires public schools receiving federal education funds to disclose information about foreign-funded activities to parents. Schools must provide parents with access to classroom materials or teacher training paid for by foreign governments or entities, and disclose details about foreign donations, contracts, or staff paid with foreign funds upon written request. Parents can request this information within 30 days, and schools must post annual summaries online. The bill aims to increase transparency about foreign influence in K-12 education, directly affecting parents of students in participating schools.

Passed Dec 4, 2025 0 co-sponsors
Co-sponsor HR 5284
Passed · Texas House · Co-sponsor
Claiming Age Clarity Act

Maddy summaryThe Claiming Age Clarity Act (HR 5284) requires the Social Security Administration to update its official terminology by January 1, 2027. It directs the replacement of specific terms: "early eligibility age" becomes "minimum monthly benefit age," "full retirement age" and "normal retirement age" become "standard monthly benefit age," and "delayed retirement credit" is eliminated, with "maximum monthly benefit age" used instead of age 70 references. This change applies to all Social Security Administration rules, regulations, guidance, and materials, both online and in print, affecting how the agency communicates retirement benefit rules to the public.

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 1262
Passed · Texas House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 5107
Passed · Texas House · Co-sponsor
Common-Sense Law Enforcement and Accountability Now in DC Act of 2025

Maddy summaryHR 5107, the Common-Sense Law Enforcement and Accountability Now in DC Act (CLEAN DC Act), repeals D.C. Law 24-345 (the 2022 Comprehensive Policing and Justice Reform Amendment Act). This bill directly affects Washington, D.C.'s policing and justice systems by reversing all changes made under that 2022 law. The key mechanism is a straightforward repeal, restoring all prior District laws as if the 2022 reform had never been enacted. The bill does not introduce new provisions but undoes existing reforms to the District’s law enforcement framework.

Passed Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6130
In committee · Texas House · Co-sponsor
ASAP Act

Maddy summaryThis bill would require Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting January 1, 2028. It defines eligible tests as FDA-cleared genomic blood tests, blood product analyses, or equivalent medical imaging methods (like protein expression or whole genome sequencing) that detect pre-symptomatic or early-stage conditions. Medicare beneficiaries would receive this coverage without cost-sharing for these specific screenings. The bill amends Medicare coverage rules to explicitly include these tests under Section 1861(nnn) of the Social Security Act.

In committee Nov 19, 2025 1 co-sponsor
Co-sponsor HRES 872
In committee · Texas House · Co-sponsor
Supporting the goals and ideals of "Creutzfeldt-Jakob Disease (CJD) Awareness Day".

Maddy summaryHRES 872 is a symbolic resolution supporting Creutzfeldt-Jakob Disease (CJD) Awareness Day, recognizing CJD as a rare, fatal brain disorder affecting approximately 1-2 people per million annually in the U.S. The resolution does not create new programs or policies but formally acknowledges the disease's impact and the importance of raising public awareness about CJD's rapid progression and challenges for patients and families. It specifically encourages recognition of CJD Awareness Day on November 12, 2025, as a way to highlight this condition. The resolution is non-binding and focuses solely on awareness, not medical research or funding.

In committee Nov 10, 2025 1 co-sponsor
Showing 71 to 80 of 458 bills
Previous 1 7 8 9 46 Next